If you’re comparing Spravato with ketamine, this article explains the differences that matter most: the exact product, route, safety process, evidence, and access requirements. It helps you ask better questions before deciding what fits your care plan.

If you’re comparing ketamine, Spravato, or infusion pricing, this article helps you sort out what a quote really includes and what insurance may or may not cover. It also gives you a simple script for asking the clinic and insurer the right questions.

If you’re preparing for a Spravato appointment, this guide explains what supervised administration looks like, how monitoring works, and what to plan for before you go. It’s a practical overview for first-time visits and anyone wanting clearer expectations.

If you’re trying to understand ketamine for OCD, this article separates early research from proven care. It explains what small studies suggest, what remains unknown, and why OCD-specific treatment decisions still need a careful clinical review.

Ketamine and esketamine sound similar, but they are not the same treatment. This guide explains how Spravato nasal spray and IV ketamine differ in approval, insurance, setting, and clinical decision-making.

What would a psychiatrist do first if depression arrived? This evidence-informed depression playbook explains the practical steps that belong before, alongside, and sometimes after medication.

How many ketamine treatments do you need? Treatment involves two phases: induction (rapid relief) and maintenance (sustaining results). For FDA-approved Spravato, induction is typically 8 sessions over 4 weeks. For IV ketamine, it’s usually 6 sessions over 2-3 weeks. If you respond well, clinicians transition you to a maintenance schedule, spacing visits out as much as possible to keep depression in remission.